Ionis Pharmaceuticals
IONS
#3217
Rank
โ‚ฌ4.39 B
Marketcap
26,40ย โ‚ฌ
Share price
6.41%
Change (1 day)
-58.11%
Change (1 year)

EPS for Ionis Pharmaceuticals (IONS)

EPS in 2026 (TTM): -2,97ย โ‚ฌ

According to Ionis Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -3,14ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,14ย โ‚ฌ an increase over its 2024 EPS that were of -2,76ย โ‚ฌ.

EPS history for Ionis Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-2,97ย โ‚ฌ38.57%
2025-2,14ย โ‚ฌ-22.37%
2024-2,76ย โ‚ฌ18.75%
2023-2,33ย โ‚ฌ34.74%
2022-1,73ย โ‚ฌ850%
2021-0,18ย โ‚ฌ-93.51%
2020-2,80ย โ‚ฌ-245.28%
20191,93ย โ‚ฌ6.53%
20181,81ย โ‚ฌ-10050%
2017-0,01817ย โ‚ฌ-97.22%
2016-0,65ย โ‚ฌ-1.37%
2015-0,66ย โ‚ฌ114.71%
2014-0,31ย โ‚ฌ-35.85%
2013-0,48ย โ‚ฌ-18.46%
2012-0,59ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
-0,05450ย โ‚ฌ-98.27% Bahamas
NRC Health
NRC
0,26ย โ‚ฌ-108.38%๐Ÿ‡บ๐Ÿ‡ธ USA